STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV (NASDAQ: CRWV) holder files Form 144 to sell 25,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV received a Form 144 notice from a shareholder planning to sell 25,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,401,000. The filing lists 386,401,201 common shares outstanding and identifies NASDAQ as the trading market.

The 25,000 shares to be sold are described as founder shares acquired on 02/25/2019. The document also details extensive prior three‑month sales under Rule 10b5‑1 trading plans by various trusts and entities associated with the same address, including individual sales such as 102,835 common shares sold for $9,799,589.34 on 01/20/2026 and 257,733 shares sold for $19,592,527.61 on 12/01/2025.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the CRWV Form 144 filing disclose?

The Form 144 discloses a plan to sell 25,000 CRWV common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,401,000. It also lists recent Rule 10b5‑1 sales by related trusts and entities over the prior three months.

How many CRWV shares are covered by the planned sale in this Form 144?

The planned sale covers 25,000 shares of CRWV common stock. These are identified as founder shares acquired on 02/25/2019, and the filing shows an aggregate market value of $2,401,000 for this block based on the market price at the time of the notice.

How many CRWV shares are reported as outstanding in the Form 144?

The filing reports 386,401,201 common shares outstanding. This figure appears in the securities information table alongside the planned 25,000‑share sale, providing context on the size of the issuer’s equity base relative to the proposed disposition.

When were the CRWV shares in this Form 144 originally acquired?

The 25,000 CRWV common shares are described as founder shares acquired on 02/25/2019. The filing also notes the same date as the payment date, with the nature of payment recorded as “N/A,” indicating no additional detail on consideration in this excerpt.

Which broker is handling the planned CRWV share sale in the Form 144?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. NASDAQ is listed as the securities exchange for the common stock being sold.

What prior CRWV stock sales are summarized in the Form 144?

The filing lists extensive prior three‑month sales of CRWV common stock under Rule 10b5‑1 for multiple trusts and entities. Examples include 102,835 shares sold for $9,799,589.34 on 01/20/2026 and 257,733 shares sold for $19,592,527.61 on 12/01/2025.